Article

Rising Out-of-Pocket Cost Concerns Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
5 experts in this video
Related Content
AACR 2025: Liposomal Annamycin May Enhance Chemotherapy Efficacy Across Hematologic and Solid Tumors
May 1st 2025

AACR 2025: Liposomal Annamycin May Enhance Chemotherapy Efficacy Across Hematologic and Solid Tumors

Alana Hippensteele, Lead Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP
May 1st 2025

Camber Pharmaceuticals Announces Addition of Phenylephrine Hydrochloride Injection, USP

The RIVAWAR Trial and ACS Guidelines for LV Thrombus
April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions
May 1st 2025

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Melissa Garcia, PharmD Candidate Saro Arakelians, PharmD
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
May 1st 2025

Adult RSV-ARI Linked to Higher Death Risk and Health Care Costs

Kennedy Ferruggia, Assistant Editor